Delivery Order SPE2DB22D1202-SPE2DB25FUSL9
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,510.07, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, under a Firm Fixed Price contract valued at $1,149.50. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,820.87, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and has a completion date of September 21, 2023. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award, valued at $4,257.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 2, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and there is no information provided on...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,008.39 delivery order contract is for NAYZILAM 5 MG NASAL SPRAYS, with an ultimate completion date of April 26, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.97 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, and has a performance period ending on January 15, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp for the delivery of 4,566,447,110 units of NAYZILAM 5 MG NASAL SPRAYS. The $1,194.74 firm fixed-price Delivery Order has a completion date of November 18, 2024 and is not designated under any set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $1,008.39, is a delivery order for 4,564,389,901 units of the pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. The contract has no set-aside designation and is a firm fixed-price arrangement with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,344.52 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG nasal sprays, with a period of performance ending on November 19, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $1,008.39, is for the delivery of 4565068572 NAYZILAM 5 MG NASAL SPRAYS. This is a firm fixed-price delivery order contract with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...